Search research articles
Contact Us
Filters
Showing results (101-110 of 165) with videos related to
Page
of 17
Sort By:
Clinics in Chest Medicine
|
October 19, 2025
Neuroendocrine Hyperplasia of Infancy and Diffuse Idiopathic Neuroendocrine Cell Hyperplasia: Two Faces of Pulmonary Neuroendocrine Cell Pathology
Julie C Worrell, Helen O'Brien, Sean Quinn, et al.
American Journal of Respiratory Cell and Molecular Biology
|
May 31, 2024
Reexamining the Role of Pulmonary Lipids in the Pathogenesis of Pulmonary Fibrosis
Marissa O'Callaghan, Elizabeth J Tarling, James P Bridges, et al.
European Radiology
|
July 23, 2024
Meta-analysis of [<sup>18</sup>F]FDG-PET/CT in pulmonary sarcoidosis
Ryan Donnelly, Michael McDermott, Gerry McManus, et al.
Endocrine-Related Cancer
|
July 6, 2023
DIPNECH: pragmatic approach, uncertainties, notable associations, and a proposal for an improved definition
Bilal F Samhouri, Thorvardur R Halfdanarson, Chi Wan Koo, et al.
Thorax
|
August 6, 2021
Atypical cause of bronchial cut-off sign
Brian Gaffney, Liam Chawke, Michaela Larkin, et al.
Nature Reviews. Disease Primers
|
March 9, 2019
Pulmonary alveolar proteinosis
Bruce C Trapnell, Koh Nakata, Francesco Bonella, et al.
Chest
|
February 27, 2025
Deciphering the Role of Fluorodeoxyglucose-Positron Emission Tomography/CT Imaging in the Management of Sarcoidosis
Ryan Donnelly, Alessandro N Franciosi, Sarah H Forde, et al.
Trials
|
May 27, 2020
The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial
Eoin Feeney, Deborah Wallace, Aoife Cotter, et al.
Journal of Innate Immunity
|
August 10, 2025
A review of Proteases and Antiproteases for Immune Regulation and Potential Therapeutic Application in Pulmonary Fibrosis
Sara Waqas Ahmed, Debananda Gogoi, Luke Forde, et al.
American Journal of Respiratory Cell and Molecular Biology
|
July 17, 2019
Increased Pulmonary GM-CSF Causes Alveolar Macrophage Accumulation. Mechanistic Implications for Desquamative Interstitial Pneumonitis
Takuji Suzuki, Cormac McCarthy, Brenna C Carey, et al.
Page
of 17
Search research articles
Search
Showing results (101-110 of 165) with videos related to
Sort By:
Page
of 17
Clinics in Chest Medicine
|
October 19, 2025
Neuroendocrine Hyperplasia of Infancy and Diffuse Idiopathic Neuroendocrine Cell Hyperplasia: Two Faces of Pulmonary Neuroendocrine Cell Pathology
Julie C Worrell, Helen O'Brien, Sean Quinn, et al.
American Journal of Respiratory Cell and Molecular Biology
|
May 31, 2024
Reexamining the Role of Pulmonary Lipids in the Pathogenesis of Pulmonary Fibrosis
Marissa O'Callaghan, Elizabeth J Tarling, James P Bridges, et al.
European Radiology
|
July 23, 2024
Meta-analysis of [<sup>18</sup>F]FDG-PET/CT in pulmonary sarcoidosis
Ryan Donnelly, Michael McDermott, Gerry McManus, et al.
Endocrine-Related Cancer
|
July 6, 2023
DIPNECH: pragmatic approach, uncertainties, notable associations, and a proposal for an improved definition
Bilal F Samhouri, Thorvardur R Halfdanarson, Chi Wan Koo, et al.
Thorax
|
August 6, 2021
Atypical cause of bronchial cut-off sign
Brian Gaffney, Liam Chawke, Michaela Larkin, et al.
Nature Reviews. Disease Primers
|
March 9, 2019
Pulmonary alveolar proteinosis
Bruce C Trapnell, Koh Nakata, Francesco Bonella, et al.
Chest
|
February 27, 2025
Deciphering the Role of Fluorodeoxyglucose-Positron Emission Tomography/CT Imaging in the Management of Sarcoidosis
Ryan Donnelly, Alessandro N Franciosi, Sarah H Forde, et al.
Trials
|
May 27, 2020
The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial
Eoin Feeney, Deborah Wallace, Aoife Cotter, et al.
Journal of Innate Immunity
|
August 10, 2025
A review of Proteases and Antiproteases for Immune Regulation and Potential Therapeutic Application in Pulmonary Fibrosis
Sara Waqas Ahmed, Debananda Gogoi, Luke Forde, et al.
American Journal of Respiratory Cell and Molecular Biology
|
July 17, 2019
Increased Pulmonary GM-CSF Causes Alveolar Macrophage Accumulation. Mechanistic Implications for Desquamative Interstitial Pneumonitis
Takuji Suzuki, Cormac McCarthy, Brenna C Carey, et al.
Page
of 17